Login / Signup

Evaluating the reactogenicity of COVID-19 vaccines from network-meta analyses.

Giorgia TiozzoTimon LouwsmaStefan R A KoningsGerard T VondelingJudith Perez GomezMaarten Jacobus PostmaRoel D Freriks
Published in: Expert review of vaccines (2023)
The reduced chance of experiencing an adverse event with some COVID-19 vaccines may help to overcome vaccine hesitancy in population groups with concerns about the side effects of vaccines.
Keyphrases
  • coronavirus disease
  • sars cov
  • meta analyses
  • systematic review
  • randomized controlled trial
  • emergency department
  • respiratory syndrome coronavirus